CTRI/2023/07/055325招募中4 期
Efficacy and Safety of Sacubitril/Valsartan as an add-on to the standard therapy in patients of Heart Failure: A Prospective, Randomized Study - NI
Pt B.D. Sharma UHS Rohtak0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Presence of New York Heart Association functional class II–III
- •-Echocardiographic evidence of LV diastolic dysfunction/systolic dysfunction
- •-Willing to give written informed consent
排除标准
- •-Clinically unstable patient as defined by any change in diuretic dose in the month before enrollment
- •-Significant valvular heart disease, pericardial disease, hypertrophic or restrictive cardiomyopathy
- •-Unstable angina or MI within the past 4 weeks
- •-Alternative probable cause of patient’s symptoms (e.g. significant pulmonary disease)
- •-Pregnant or lactating females
- •-Currently on ACEI/ARB/ARNi/NSAIDS/Steroids
研究者
相似试验
尚未招募
1 期
Safety and efficacy of Sacubitril/Valsartan in blood pressure control of dialysis patientsCTRI/2020/02/023116Postgraduate Institute of Medical Education and Research
尚未招募
Unknown
Safety and efficacy of sacubitril/valsartan in patients with congenital heart diease with systemic right ventricular dysfunction – a prospective observational studyCTRI/2024/02/063203Pediatric Cardiac Society of India
已完成
Unknown
The efficacy of sacubitril/valsartan in patients with poorly controlled essential hypertension.HypertensionJPRN-UMIN000052604Tachibanadai clinic55
招募中
2 期
Investigating the effect of valsartan sacubitril on left ventricular functioIRCT20240117060713N1Ahvaz University of Medical Sciences92
招募中
3 期
The Effect of Sacubitril-Valsartan on RV functioDilated cardiomyopathyIschemic cardiomyopathyIRCT20230926059524N1Iran University of Medical Sciences84